Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Neoplasms | 7 | 2026 | 546 | 2.930 |
Why?
|
| Carcinoma, Renal Cell | 6 | 2025 | 361 | 2.490 |
Why?
|
| Biomarkers, Tumor | 5 | 2025 | 1660 | 1.590 |
Why?
|
| Adenoma, Oxyphilic | 2 | 2025 | 37 | 1.070 |
Why?
|
| Amyloidosis | 3 | 2024 | 129 | 0.910 |
Why?
|
| Margins of Excision | 1 | 2024 | 45 | 0.860 |
Why?
|
| GATA3 Transcription Factor | 1 | 2024 | 52 | 0.860 |
Why?
|
| MAP Kinase Signaling System | 1 | 2025 | 200 | 0.850 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2025 | 178 | 0.820 |
Why?
|
| Immunoglobulin Light-chain Amyloidosis | 2 | 2024 | 24 | 0.820 |
Why?
|
| Mutation | 3 | 2025 | 4272 | 0.810 |
Why?
|
| BRCA2 Protein | 1 | 2024 | 173 | 0.800 |
Why?
|
| Prostatectomy | 1 | 2024 | 478 | 0.680 |
Why?
|
| Kidney | 1 | 2026 | 1111 | 0.660 |
Why?
|
| Prostatic Neoplasms | 1 | 2024 | 1775 | 0.400 |
Why?
|
| Immunohistochemistry | 2 | 2024 | 1799 | 0.320 |
Why?
|
| Aged | 6 | 2026 | 20434 | 0.290 |
Why?
|
| Middle Aged | 6 | 2026 | 27573 | 0.260 |
Why?
|
| Immunoglobulin Light Chains | 2 | 2024 | 66 | 0.240 |
Why?
|
| Diagnosis, Differential | 3 | 2025 | 1546 | 0.240 |
Why?
|
| raf Kinases | 1 | 2025 | 15 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2025 | 50 | 0.230 |
Why?
|
| Male | 8 | 2026 | 44557 | 0.230 |
Why?
|
| Humans | 13 | 2026 | 93515 | 0.220 |
Why?
|
| Butyrates | 1 | 2025 | 56 | 0.220 |
Why?
|
| GTP Phosphohydrolases | 1 | 2025 | 80 | 0.220 |
Why?
|
| Vimentin | 1 | 2024 | 47 | 0.220 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2025 | 162 | 0.210 |
Why?
|
| DNA Mutational Analysis | 1 | 2025 | 543 | 0.200 |
Why?
|
| Cysteine | 1 | 2024 | 145 | 0.190 |
Why?
|
| Prostate-Specific Antigen | 1 | 2024 | 337 | 0.190 |
Why?
|
| Retrospective Studies | 3 | 2026 | 10164 | 0.180 |
Why?
|
| Atherosclerosis | 1 | 2025 | 256 | 0.180 |
Why?
|
| Biopsy | 1 | 2026 | 1175 | 0.180 |
Why?
|
| Predictive Value of Tests | 2 | 2023 | 1713 | 0.180 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2023 | 258 | 0.170 |
Why?
|
| Cardiomyopathies | 1 | 2024 | 291 | 0.170 |
Why?
|
| Female | 6 | 2026 | 48702 | 0.160 |
Why?
|
| Echocardiography | 1 | 2024 | 745 | 0.160 |
Why?
|
| Membrane Proteins | 1 | 2025 | 1264 | 0.140 |
Why?
|
| Aged, 80 and over | 2 | 2026 | 7061 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 1448 | 0.140 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2024 | 826 | 0.130 |
Why?
|
| Adult | 3 | 2026 | 27918 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2025 | 2465 | 0.120 |
Why?
|
| Signal Transduction | 1 | 2025 | 3502 | 0.110 |
Why?
|
| Heart Failure | 1 | 2023 | 1386 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 2495 | 0.070 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2025 | 12 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2025 | 136 | 0.050 |
Why?
|
| Disulfides | 1 | 2024 | 65 | 0.050 |
Why?
|
| Cholesterol, LDL | 1 | 2025 | 246 | 0.050 |
Why?
|
| Amyloid | 1 | 2024 | 104 | 0.050 |
Why?
|
| Ventricular Remodeling | 1 | 2024 | 99 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2024 | 173 | 0.050 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2023 | 145 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2024 | 355 | 0.040 |
Why?
|
| Myocardium | 1 | 2024 | 570 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2023 | 438 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2024 | 797 | 0.040 |
Why?
|
| Mice | 2 | 2025 | 12269 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2025 | 2121 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 520 | 0.040 |
Why?
|
| Animals | 2 | 2025 | 28155 | 0.030 |
Why?
|